nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP2B6—Sorafenib—thyroid cancer	0.122	0.195	CbGbCtD
Efavirenz—CYP2C19—Sorafenib—thyroid cancer	0.0775	0.124	CbGbCtD
Efavirenz—CYP2B6—Doxorubicin—thyroid cancer	0.074	0.118	CbGbCtD
Efavirenz—CYP1A2—Sorafenib—thyroid cancer	0.0715	0.114	CbGbCtD
Efavirenz—CYP2C9—Sorafenib—thyroid cancer	0.0645	0.103	CbGbCtD
Efavirenz—CYP3A4—Vandetanib—thyroid cancer	0.0622	0.0992	CbGbCtD
Efavirenz—CYP2D6—Sorafenib—thyroid cancer	0.0589	0.0941	CbGbCtD
Efavirenz—CYP3A4—Sorafenib—thyroid cancer	0.0375	0.0598	CbGbCtD
Efavirenz—CYP2D6—Doxorubicin—thyroid cancer	0.0358	0.0571	CbGbCtD
Efavirenz—CYP3A4—Doxorubicin—thyroid cancer	0.0227	0.0363	CbGbCtD
Efavirenz—Hepatic failure—Epirubicin—thyroid cancer	0.000541	0.00145	CcSEcCtD
Efavirenz—Abnormal vision—Doxorubicin—thyroid cancer	0.000541	0.00145	CcSEcCtD
Efavirenz—Mental disability—Doxorubicin—thyroid cancer	0.000538	0.00144	CcSEcCtD
Efavirenz—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000536	0.00144	CcSEcCtD
Efavirenz—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000529	0.00142	CcSEcCtD
Efavirenz—Renal failure acute—Epirubicin—thyroid cancer	0.000527	0.00141	CcSEcCtD
Efavirenz—Hot flush—Epirubicin—thyroid cancer	0.00052	0.00139	CcSEcCtD
Efavirenz—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00052	0.00139	CcSEcCtD
Efavirenz—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000515	0.00138	CcSEcCtD
Efavirenz—Menopausal symptoms—Epirubicin—thyroid cancer	0.000515	0.00138	CcSEcCtD
Efavirenz—Urticaria—Sorafenib—thyroid cancer	0.000514	0.00138	CcSEcCtD
Efavirenz—Abdominal pain—Sorafenib—thyroid cancer	0.000511	0.00137	CcSEcCtD
Efavirenz—Body temperature increased—Sorafenib—thyroid cancer	0.000511	0.00137	CcSEcCtD
Efavirenz—Renal impairment—Epirubicin—thyroid cancer	0.000511	0.00137	CcSEcCtD
Efavirenz—Dermatitis bullous—Epirubicin—thyroid cancer	0.000509	0.00136	CcSEcCtD
Efavirenz—Eczema—Doxorubicin—thyroid cancer	0.000501	0.00134	CcSEcCtD
Efavirenz—Hepatic failure—Doxorubicin—thyroid cancer	0.000501	0.00134	CcSEcCtD
Efavirenz—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000496	0.00133	CcSEcCtD
Efavirenz—Renal failure acute—Doxorubicin—thyroid cancer	0.000487	0.00131	CcSEcCtD
Efavirenz—Diplopia—Epirubicin—thyroid cancer	0.000486	0.0013	CcSEcCtD
Efavirenz—Hot flush—Doxorubicin—thyroid cancer	0.000481	0.00129	CcSEcCtD
Efavirenz—Affect lability—Epirubicin—thyroid cancer	0.000479	0.00128	CcSEcCtD
Efavirenz—Migraine—Epirubicin—thyroid cancer	0.000479	0.00128	CcSEcCtD
Efavirenz—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000477	0.00128	CcSEcCtD
Efavirenz—Menopausal symptoms—Doxorubicin—thyroid cancer	0.000477	0.00128	CcSEcCtD
Efavirenz—Hypersensitivity—Sorafenib—thyroid cancer	0.000476	0.00128	CcSEcCtD
Efavirenz—Renal impairment—Doxorubicin—thyroid cancer	0.000473	0.00127	CcSEcCtD
Efavirenz—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000471	0.00126	CcSEcCtD
Efavirenz—Asthenia—Sorafenib—thyroid cancer	0.000464	0.00124	CcSEcCtD
Efavirenz—Mood swings—Epirubicin—thyroid cancer	0.000461	0.00123	CcSEcCtD
Efavirenz—Pruritus—Sorafenib—thyroid cancer	0.000457	0.00123	CcSEcCtD
Efavirenz—Ataxia—Epirubicin—thyroid cancer	0.000457	0.00122	CcSEcCtD
Efavirenz—Blood creatinine increased—Epirubicin—thyroid cancer	0.000456	0.00122	CcSEcCtD
Efavirenz—Diplopia—Doxorubicin—thyroid cancer	0.00045	0.00121	CcSEcCtD
Efavirenz—Migraine—Doxorubicin—thyroid cancer	0.000443	0.00119	CcSEcCtD
Efavirenz—Affect lability—Doxorubicin—thyroid cancer	0.000443	0.00119	CcSEcCtD
Efavirenz—Hypokalaemia—Epirubicin—thyroid cancer	0.000443	0.00119	CcSEcCtD
Efavirenz—Diarrhoea—Sorafenib—thyroid cancer	0.000442	0.00119	CcSEcCtD
Efavirenz—Breast disorder—Epirubicin—thyroid cancer	0.000439	0.00118	CcSEcCtD
Efavirenz—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000438	0.00117	CcSEcCtD
Efavirenz—Nasopharyngitis—Epirubicin—thyroid cancer	0.000435	0.00116	CcSEcCtD
Efavirenz—Muscular weakness—Epirubicin—thyroid cancer	0.000429	0.00115	CcSEcCtD
Efavirenz—Dizziness—Sorafenib—thyroid cancer	0.000428	0.00115	CcSEcCtD
Efavirenz—Mood swings—Doxorubicin—thyroid cancer	0.000426	0.00114	CcSEcCtD
Efavirenz—Abdominal distension—Epirubicin—thyroid cancer	0.000423	0.00113	CcSEcCtD
Efavirenz—Ataxia—Doxorubicin—thyroid cancer	0.000423	0.00113	CcSEcCtD
Efavirenz—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000421	0.00113	CcSEcCtD
Efavirenz—Asthma—Epirubicin—thyroid cancer	0.00042	0.00113	CcSEcCtD
Efavirenz—Pancreatitis—Epirubicin—thyroid cancer	0.000412	0.0011	CcSEcCtD
Efavirenz—Vomiting—Sorafenib—thyroid cancer	0.000411	0.0011	CcSEcCtD
Efavirenz—Hypokalaemia—Doxorubicin—thyroid cancer	0.000409	0.0011	CcSEcCtD
Efavirenz—Rash—Sorafenib—thyroid cancer	0.000408	0.00109	CcSEcCtD
Efavirenz—Dermatitis—Sorafenib—thyroid cancer	0.000407	0.00109	CcSEcCtD
Efavirenz—Breast disorder—Doxorubicin—thyroid cancer	0.000407	0.00109	CcSEcCtD
Efavirenz—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000405	0.00109	CcSEcCtD
Efavirenz—Headache—Sorafenib—thyroid cancer	0.000405	0.00109	CcSEcCtD
Efavirenz—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000402	0.00108	CcSEcCtD
Efavirenz—Pancytopenia—Epirubicin—thyroid cancer	0.000399	0.00107	CcSEcCtD
Efavirenz—Muscular weakness—Doxorubicin—thyroid cancer	0.000397	0.00106	CcSEcCtD
Efavirenz—Abdominal distension—Doxorubicin—thyroid cancer	0.000391	0.00105	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000391	0.00105	CcSEcCtD
Efavirenz—Asthma—Doxorubicin—thyroid cancer	0.000389	0.00104	CcSEcCtD
Efavirenz—Nausea—Sorafenib—thyroid cancer	0.000384	0.00103	CcSEcCtD
Efavirenz—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000384	0.00103	CcSEcCtD
Efavirenz—Pancreatitis—Doxorubicin—thyroid cancer	0.000381	0.00102	CcSEcCtD
Efavirenz—Hyperglycaemia—Epirubicin—thyroid cancer	0.000379	0.00102	CcSEcCtD
Efavirenz—Pneumonia—Epirubicin—thyroid cancer	0.000377	0.00101	CcSEcCtD
Efavirenz—Infestation—Epirubicin—thyroid cancer	0.000375	0.001	CcSEcCtD
Efavirenz—Drowsiness—Epirubicin—thyroid cancer	0.000375	0.001	CcSEcCtD
Efavirenz—Infestation NOS—Epirubicin—thyroid cancer	0.000375	0.001	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000371	0.000995	CcSEcCtD
Efavirenz—Pancytopenia—Doxorubicin—thyroid cancer	0.000369	0.000989	CcSEcCtD
Efavirenz—Renal failure—Epirubicin—thyroid cancer	0.000368	0.000987	CcSEcCtD
Efavirenz—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000367	0.000984	CcSEcCtD
Efavirenz—Jaundice—Epirubicin—thyroid cancer	0.000365	0.000978	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000361	0.000968	CcSEcCtD
Efavirenz—Sweating—Epirubicin—thyroid cancer	0.000359	0.000962	CcSEcCtD
Efavirenz—Haematuria—Epirubicin—thyroid cancer	0.000357	0.000957	CcSEcCtD
Efavirenz—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000355	0.000951	CcSEcCtD
Efavirenz—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000354	0.000949	CcSEcCtD
Efavirenz—Sinusitis—Epirubicin—thyroid cancer	0.000352	0.000942	CcSEcCtD
Efavirenz—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000351	0.00094	CcSEcCtD
Efavirenz—Pneumonia—Doxorubicin—thyroid cancer	0.000349	0.000934	CcSEcCtD
Efavirenz—Drowsiness—Doxorubicin—thyroid cancer	0.000347	0.000929	CcSEcCtD
Efavirenz—Infestation—Doxorubicin—thyroid cancer	0.000347	0.000929	CcSEcCtD
Efavirenz—Infestation NOS—Doxorubicin—thyroid cancer	0.000347	0.000929	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000344	0.000921	CcSEcCtD
Efavirenz—Renal failure—Doxorubicin—thyroid cancer	0.000341	0.000913	CcSEcCtD
Efavirenz—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00034	0.00091	CcSEcCtD
Efavirenz—Jaundice—Doxorubicin—thyroid cancer	0.000338	0.000905	CcSEcCtD
Efavirenz—Rhinitis—Epirubicin—thyroid cancer	0.000337	0.000903	CcSEcCtD
Efavirenz—Hepatitis—Epirubicin—thyroid cancer	0.000336	0.000901	CcSEcCtD
Efavirenz—Hypoaesthesia—Epirubicin—thyroid cancer	0.000335	0.000897	CcSEcCtD
Efavirenz—Sweating—Doxorubicin—thyroid cancer	0.000332	0.00089	CcSEcCtD
Efavirenz—Urinary tract disorder—Epirubicin—thyroid cancer	0.000332	0.00089	CcSEcCtD
Efavirenz—Oedema peripheral—Epirubicin—thyroid cancer	0.000331	0.000888	CcSEcCtD
Efavirenz—Haematuria—Doxorubicin—thyroid cancer	0.000331	0.000886	CcSEcCtD
Efavirenz—Connective tissue disorder—Epirubicin—thyroid cancer	0.000331	0.000885	CcSEcCtD
Efavirenz—Urethral disorder—Epirubicin—thyroid cancer	0.00033	0.000883	CcSEcCtD
Efavirenz—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000328	0.000878	CcSEcCtD
Efavirenz—Sinusitis—Doxorubicin—thyroid cancer	0.000325	0.000871	CcSEcCtD
Efavirenz—Visual impairment—Epirubicin—thyroid cancer	0.000324	0.000868	CcSEcCtD
Efavirenz—Erythema multiforme—Epirubicin—thyroid cancer	0.000318	0.000852	CcSEcCtD
Efavirenz—Eye disorder—Epirubicin—thyroid cancer	0.000314	0.000842	CcSEcCtD
Efavirenz—Tinnitus—Epirubicin—thyroid cancer	0.000314	0.00084	CcSEcCtD
Efavirenz—Flushing—Epirubicin—thyroid cancer	0.000312	0.000836	CcSEcCtD
Efavirenz—Cardiac disorder—Epirubicin—thyroid cancer	0.000312	0.000836	CcSEcCtD
Efavirenz—Rhinitis—Doxorubicin—thyroid cancer	0.000312	0.000836	CcSEcCtD
Efavirenz—Hepatitis—Doxorubicin—thyroid cancer	0.000311	0.000834	CcSEcCtD
Efavirenz—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00031	0.00083	CcSEcCtD
Efavirenz—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000307	0.000823	CcSEcCtD
Efavirenz—Oedema peripheral—Doxorubicin—thyroid cancer	0.000307	0.000821	CcSEcCtD
Efavirenz—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000306	0.000819	CcSEcCtD
Efavirenz—Angiopathy—Epirubicin—thyroid cancer	0.000305	0.000818	CcSEcCtD
Efavirenz—Urethral disorder—Doxorubicin—thyroid cancer	0.000305	0.000817	CcSEcCtD
Efavirenz—Immune system disorder—Epirubicin—thyroid cancer	0.000304	0.000814	CcSEcCtD
Efavirenz—Mediastinal disorder—Epirubicin—thyroid cancer	0.000303	0.000812	CcSEcCtD
Efavirenz—Arrhythmia—Epirubicin—thyroid cancer	0.0003	0.000805	CcSEcCtD
Efavirenz—Visual impairment—Doxorubicin—thyroid cancer	0.0003	0.000803	CcSEcCtD
Efavirenz—Alopecia—Epirubicin—thyroid cancer	0.000297	0.000796	CcSEcCtD
Efavirenz—Erythema multiforme—Doxorubicin—thyroid cancer	0.000294	0.000788	CcSEcCtD
Efavirenz—Malnutrition—Epirubicin—thyroid cancer	0.000293	0.000784	CcSEcCtD
Efavirenz—Erythema—Epirubicin—thyroid cancer	0.000293	0.000784	CcSEcCtD
Efavirenz—Eye disorder—Doxorubicin—thyroid cancer	0.000291	0.000779	CcSEcCtD
Efavirenz—Tinnitus—Doxorubicin—thyroid cancer	0.00029	0.000777	CcSEcCtD
Efavirenz—Flushing—Doxorubicin—thyroid cancer	0.000289	0.000774	CcSEcCtD
Efavirenz—Cardiac disorder—Doxorubicin—thyroid cancer	0.000289	0.000774	CcSEcCtD
Efavirenz—Flatulence—Epirubicin—thyroid cancer	0.000289	0.000773	CcSEcCtD
Efavirenz—Tension—Epirubicin—thyroid cancer	0.000287	0.00077	CcSEcCtD
Efavirenz—Dysgeusia—Epirubicin—thyroid cancer	0.000287	0.000768	CcSEcCtD
Efavirenz—Nervousness—Epirubicin—thyroid cancer	0.000284	0.000762	CcSEcCtD
Efavirenz—Back pain—Epirubicin—thyroid cancer	0.000283	0.000759	CcSEcCtD
Efavirenz—Angiopathy—Doxorubicin—thyroid cancer	0.000282	0.000756	CcSEcCtD
Efavirenz—Immune system disorder—Doxorubicin—thyroid cancer	0.000281	0.000753	CcSEcCtD
Efavirenz—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00028	0.000751	CcSEcCtD
Efavirenz—Arrhythmia—Doxorubicin—thyroid cancer	0.000278	0.000745	CcSEcCtD
Efavirenz—Vision blurred—Epirubicin—thyroid cancer	0.000276	0.000739	CcSEcCtD
Efavirenz—Alopecia—Doxorubicin—thyroid cancer	0.000275	0.000737	CcSEcCtD
Efavirenz—Ill-defined disorder—Epirubicin—thyroid cancer	0.000272	0.000728	CcSEcCtD
Efavirenz—Malnutrition—Doxorubicin—thyroid cancer	0.000271	0.000726	CcSEcCtD
Efavirenz—Erythema—Doxorubicin—thyroid cancer	0.000271	0.000726	CcSEcCtD
Efavirenz—Anaemia—Epirubicin—thyroid cancer	0.000271	0.000725	CcSEcCtD
Efavirenz—Agitation—Epirubicin—thyroid cancer	0.000269	0.000721	CcSEcCtD
Efavirenz—Flatulence—Doxorubicin—thyroid cancer	0.000267	0.000715	CcSEcCtD
Efavirenz—Tension—Doxorubicin—thyroid cancer	0.000266	0.000712	CcSEcCtD
Efavirenz—Dysgeusia—Doxorubicin—thyroid cancer	0.000265	0.000711	CcSEcCtD
Efavirenz—Malaise—Epirubicin—thyroid cancer	0.000264	0.000707	CcSEcCtD
Efavirenz—Nervousness—Doxorubicin—thyroid cancer	0.000263	0.000705	CcSEcCtD
Efavirenz—Vertigo—Epirubicin—thyroid cancer	0.000263	0.000705	CcSEcCtD
Efavirenz—Syncope—Epirubicin—thyroid cancer	0.000263	0.000703	CcSEcCtD
Efavirenz—Back pain—Doxorubicin—thyroid cancer	0.000262	0.000702	CcSEcCtD
Efavirenz—Palpitations—Epirubicin—thyroid cancer	0.000259	0.000693	CcSEcCtD
Efavirenz—Loss of consciousness—Epirubicin—thyroid cancer	0.000257	0.000689	CcSEcCtD
Efavirenz—Cough—Epirubicin—thyroid cancer	0.000256	0.000685	CcSEcCtD
Efavirenz—Vision blurred—Doxorubicin—thyroid cancer	0.000255	0.000684	CcSEcCtD
Efavirenz—Convulsion—Epirubicin—thyroid cancer	0.000254	0.00068	CcSEcCtD
Efavirenz—Hypertension—Epirubicin—thyroid cancer	0.000253	0.000677	CcSEcCtD
Efavirenz—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000251	0.000673	CcSEcCtD
Efavirenz—Anaemia—Doxorubicin—thyroid cancer	0.00025	0.000671	CcSEcCtD
Efavirenz—Arthralgia—Epirubicin—thyroid cancer	0.000249	0.000668	CcSEcCtD
Efavirenz—Myalgia—Epirubicin—thyroid cancer	0.000249	0.000668	CcSEcCtD
Efavirenz—Chest pain—Epirubicin—thyroid cancer	0.000249	0.000668	CcSEcCtD
Efavirenz—Agitation—Doxorubicin—thyroid cancer	0.000249	0.000667	CcSEcCtD
Efavirenz—Anxiety—Epirubicin—thyroid cancer	0.000248	0.000666	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000248	0.000663	CcSEcCtD
Efavirenz—Discomfort—Epirubicin—thyroid cancer	0.000246	0.00066	CcSEcCtD
Efavirenz—Malaise—Doxorubicin—thyroid cancer	0.000244	0.000655	CcSEcCtD
Efavirenz—Dry mouth—Epirubicin—thyroid cancer	0.000244	0.000653	CcSEcCtD
Efavirenz—Vertigo—Doxorubicin—thyroid cancer	0.000243	0.000652	CcSEcCtD
Efavirenz—Syncope—Doxorubicin—thyroid cancer	0.000243	0.000651	CcSEcCtD
Efavirenz—Confusional state—Epirubicin—thyroid cancer	0.000241	0.000646	CcSEcCtD
Efavirenz—Palpitations—Doxorubicin—thyroid cancer	0.000239	0.000641	CcSEcCtD
Efavirenz—Loss of consciousness—Doxorubicin—thyroid cancer	0.000238	0.000638	CcSEcCtD
Efavirenz—Cough—Doxorubicin—thyroid cancer	0.000236	0.000633	CcSEcCtD
Efavirenz—Shock—Epirubicin—thyroid cancer	0.000235	0.00063	CcSEcCtD
Efavirenz—Convulsion—Doxorubicin—thyroid cancer	0.000235	0.000629	CcSEcCtD
Efavirenz—Nervous system disorder—Epirubicin—thyroid cancer	0.000234	0.000628	CcSEcCtD
Efavirenz—Thrombocytopenia—Epirubicin—thyroid cancer	0.000234	0.000627	CcSEcCtD
Efavirenz—Hypertension—Doxorubicin—thyroid cancer	0.000234	0.000627	CcSEcCtD
Efavirenz—Tachycardia—Epirubicin—thyroid cancer	0.000233	0.000625	CcSEcCtD
Efavirenz—Skin disorder—Epirubicin—thyroid cancer	0.000232	0.000622	CcSEcCtD
Efavirenz—Hyperhidrosis—Epirubicin—thyroid cancer	0.000231	0.000619	CcSEcCtD
Efavirenz—Myalgia—Doxorubicin—thyroid cancer	0.000231	0.000618	CcSEcCtD
Efavirenz—Chest pain—Doxorubicin—thyroid cancer	0.000231	0.000618	CcSEcCtD
Efavirenz—Arthralgia—Doxorubicin—thyroid cancer	0.000231	0.000618	CcSEcCtD
Efavirenz—Anxiety—Doxorubicin—thyroid cancer	0.00023	0.000616	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000229	0.000614	CcSEcCtD
Efavirenz—Discomfort—Doxorubicin—thyroid cancer	0.000228	0.000611	CcSEcCtD
Efavirenz—Anorexia—Epirubicin—thyroid cancer	0.000228	0.00061	CcSEcCtD
Efavirenz—Dry mouth—Doxorubicin—thyroid cancer	0.000226	0.000604	CcSEcCtD
Efavirenz—Confusional state—Doxorubicin—thyroid cancer	0.000223	0.000597	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000218	0.000583	CcSEcCtD
Efavirenz—Shock—Doxorubicin—thyroid cancer	0.000218	0.000583	CcSEcCtD
Efavirenz—Nervous system disorder—Doxorubicin—thyroid cancer	0.000217	0.000581	CcSEcCtD
Efavirenz—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000216	0.00058	CcSEcCtD
Efavirenz—Insomnia—Epirubicin—thyroid cancer	0.000216	0.000579	CcSEcCtD
Efavirenz—Tachycardia—Doxorubicin—thyroid cancer	0.000216	0.000578	CcSEcCtD
Efavirenz—Skin disorder—Doxorubicin—thyroid cancer	0.000215	0.000575	CcSEcCtD
Efavirenz—Paraesthesia—Epirubicin—thyroid cancer	0.000215	0.000575	CcSEcCtD
Efavirenz—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000214	0.000573	CcSEcCtD
Efavirenz—Dyspnoea—Epirubicin—thyroid cancer	0.000213	0.000571	CcSEcCtD
Efavirenz—Somnolence—Epirubicin—thyroid cancer	0.000212	0.000569	CcSEcCtD
Efavirenz—Anorexia—Doxorubicin—thyroid cancer	0.000211	0.000565	CcSEcCtD
Efavirenz—Dyspepsia—Epirubicin—thyroid cancer	0.00021	0.000564	CcSEcCtD
Efavirenz—Decreased appetite—Epirubicin—thyroid cancer	0.000208	0.000557	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000206	0.000553	CcSEcCtD
Efavirenz—Fatigue—Epirubicin—thyroid cancer	0.000206	0.000552	CcSEcCtD
Efavirenz—Pain—Epirubicin—thyroid cancer	0.000204	0.000547	CcSEcCtD
Efavirenz—Constipation—Epirubicin—thyroid cancer	0.000204	0.000547	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000201	0.00054	CcSEcCtD
Efavirenz—Insomnia—Doxorubicin—thyroid cancer	0.0002	0.000536	CcSEcCtD
Efavirenz—Paraesthesia—Doxorubicin—thyroid cancer	0.000199	0.000532	CcSEcCtD
Efavirenz—Dyspnoea—Doxorubicin—thyroid cancer	0.000197	0.000528	CcSEcCtD
Efavirenz—Feeling abnormal—Epirubicin—thyroid cancer	0.000197	0.000528	CcSEcCtD
Efavirenz—Somnolence—Doxorubicin—thyroid cancer	0.000197	0.000527	CcSEcCtD
Efavirenz—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000195	0.000524	CcSEcCtD
Efavirenz—Dyspepsia—Doxorubicin—thyroid cancer	0.000195	0.000521	CcSEcCtD
Efavirenz—Decreased appetite—Doxorubicin—thyroid cancer	0.000192	0.000515	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000191	0.000511	CcSEcCtD
Efavirenz—Fatigue—Doxorubicin—thyroid cancer	0.000191	0.000511	CcSEcCtD
Efavirenz—Urticaria—Epirubicin—thyroid cancer	0.00019	0.000509	CcSEcCtD
Efavirenz—Pain—Doxorubicin—thyroid cancer	0.000189	0.000507	CcSEcCtD
Efavirenz—Constipation—Doxorubicin—thyroid cancer	0.000189	0.000507	CcSEcCtD
Efavirenz—Body temperature increased—Epirubicin—thyroid cancer	0.000189	0.000506	CcSEcCtD
Efavirenz—Abdominal pain—Epirubicin—thyroid cancer	0.000189	0.000506	CcSEcCtD
Efavirenz—Feeling abnormal—Doxorubicin—thyroid cancer	0.000182	0.000488	CcSEcCtD
Efavirenz—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000181	0.000484	CcSEcCtD
Efavirenz—Hypersensitivity—Epirubicin—thyroid cancer	0.000176	0.000472	CcSEcCtD
Efavirenz—Urticaria—Doxorubicin—thyroid cancer	0.000176	0.000471	CcSEcCtD
Efavirenz—Body temperature increased—Doxorubicin—thyroid cancer	0.000175	0.000468	CcSEcCtD
Efavirenz—Abdominal pain—Doxorubicin—thyroid cancer	0.000175	0.000468	CcSEcCtD
Efavirenz—Asthenia—Epirubicin—thyroid cancer	0.000171	0.000459	CcSEcCtD
Efavirenz—Pruritus—Epirubicin—thyroid cancer	0.000169	0.000453	CcSEcCtD
Efavirenz—Diarrhoea—Epirubicin—thyroid cancer	0.000164	0.000438	CcSEcCtD
Efavirenz—Hypersensitivity—Doxorubicin—thyroid cancer	0.000163	0.000436	CcSEcCtD
Efavirenz—Asthenia—Doxorubicin—thyroid cancer	0.000159	0.000425	CcSEcCtD
Efavirenz—Dizziness—Epirubicin—thyroid cancer	0.000158	0.000423	CcSEcCtD
Efavirenz—Pruritus—Doxorubicin—thyroid cancer	0.000156	0.000419	CcSEcCtD
Efavirenz—Vomiting—Epirubicin—thyroid cancer	0.000152	0.000407	CcSEcCtD
Efavirenz—Diarrhoea—Doxorubicin—thyroid cancer	0.000151	0.000405	CcSEcCtD
Efavirenz—Rash—Epirubicin—thyroid cancer	0.000151	0.000404	CcSEcCtD
Efavirenz—Dermatitis—Epirubicin—thyroid cancer	0.000151	0.000403	CcSEcCtD
Efavirenz—Headache—Epirubicin—thyroid cancer	0.00015	0.000401	CcSEcCtD
Efavirenz—Dizziness—Doxorubicin—thyroid cancer	0.000146	0.000392	CcSEcCtD
Efavirenz—Nausea—Epirubicin—thyroid cancer	0.000142	0.00038	CcSEcCtD
Efavirenz—Vomiting—Doxorubicin—thyroid cancer	0.000141	0.000377	CcSEcCtD
Efavirenz—Rash—Doxorubicin—thyroid cancer	0.000139	0.000373	CcSEcCtD
Efavirenz—Dermatitis—Doxorubicin—thyroid cancer	0.000139	0.000373	CcSEcCtD
Efavirenz—Headache—Doxorubicin—thyroid cancer	0.000139	0.000371	CcSEcCtD
Efavirenz—Nausea—Doxorubicin—thyroid cancer	0.000131	0.000352	CcSEcCtD
